MitoSense
Latest round
- Seed
Last raised
- Jan 2024
Total raised
- $1.9M
Investors
- 1
About MitoSense
Based in Virginia, US, and founded in 2019, MitoSense, Inc. operates as a biotechnology company that focuses on securing the development of treatments for neurodegenerative diseases. The company has exclusively licensed and patent-pending technology, known as Mitochondria Organelle Transplantation (MOT), to replenish mitochondria to fight various diseases, including neurodegenerative disorders. The company offers Mitochondria Organelle Transplantation (MOT), a technology designed to combat diseases by restoring mitochondria in cells. Early research suggests its potential for alleviating symptoms of neurodegenerative disorders such as ALS, Alzheimer's, and Parkinson's. The company is engaged in collaborations to advance mitochondrial treatments, with a specific focus on neurodegenerative diseases.
Who invested in MitoSense
1 investor across 1 round
See all investors in MitoSense
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Jan 11, 2024
Amount
$1.9M
Investors
Questions about MitoSense
Who invested in MitoSense?
MitoSense has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has MitoSense raised?
MitoSense has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did MitoSense last raise money?
MitoSense's most recent round on record is a Seed, in Jan 2024.
What does MitoSense do?
Based in Virginia, US, and founded in 2019, MitoSense, Inc.
Where is MitoSense headquartered?
MitoSense is headquartered in Great Falls, US.
Which VCs invest in companies like MitoSense?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at MitoSense's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like MitoSense? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.